Mark Johnson | VP, IR |
Stephen Davis | CEO & Director |
Amanda Morgan | SVP, Chief Revenue & Customer Officer |
Charmaine Lykins | SVP, Global Product Planning & CMO |
Srdjan Stankovic | President |
Elena Ridloff | EVP & CFO |
Ritu Baral | Cowen and Company |
Charles Duncan | Cantor Fitzgerald & Co. |
Jason Butler | JMP Securities |
Gregory Renza | RBC Capital Markets |
Neena Bitritto-Garg | Citigroup |
Jeff Hung | Morgan Stanley |
Andrea Tan | Goldman Sachs Group |
Paul Matteis | Stifel, Nicolaus & Company |
Eddie Hickman | Guggenheim Securities |
Jay Olson | Oppenheimer |
Vamil Divan | Mizuho Securities |
Danielle Brill | Raymond James & Associates |
David Hoang | SMBC |
Good day, ladies and gentlemen, and welcome to ACADIA Pharmaceuticals First Quarter 2021 Financial Results Conference Call. My name is Mary, and I will be your coordinator for today. At this time, all participants are in a listen-only mode.
We will be facilitating a question-and-answer session towards the end of today's call. If at any time during the call, you require assistance, please followed by Zero and a coordinator will be will be happy to assist you.